Global Graft versus Host Disease Market Assessment, By Disease Type [Acute Graft versus Host Disease, Chronic Graft versus Host Disease], By Drug Class [Monoclonal Antibodies, Immunosuppressive Drugs, Steroids, TNF Inhibitors, Others], By Route of Administration [Oral, Intravenous, Others], By End-user [Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others], By Region, Opportunities and Forecast, 2017-2031F

Graft Versus Host Disease (GvHD) Treatment Market is projected to witness a CAGR of 9.51% during the forecast period 2024-2031, growing from USD 2.99 billion in 2023 to USD 6.19 billion in 2031.

Graft Versus Host Disease (GvHD) Treatment Market Report 2031

Global Graft Versus Host Disease Market Assessment, Opportunities and Forecast, 2017-2031F

Graft versus host disease market is expected to experience growth due to increasing demand of transplantation procedures, rising number of symptoms seen post this procedure, advancements in technology, and government initiatives. 

FAQs

Industry Reports

Blogs

Case Studies

Industry News

Press Release

Infographics